XXIV Congresso Nazionale AMD | Firenze, 5-8 novembre 2023 Condividi:FacebookTwitterLinkedin Post navigation Four-year visual outcomes in the protocol W randomized trial of intravitreous aflibercept for prevention of vision-threatening complications of diabetic retinopathyMeta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin – an update including recently developed GLP‐1 receptor agonists and the GIP/GLP‐1 receptor co‐agonist tirzepatide
